Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

We have used RNase protection to measure oxygen-dependent changes in erythropoietin (EPO) mRNA in isolated perfused kidneys and to compare the effect of hypoxia with the response to inhibitors of oxidative phosphorylation. In well-oxygenated kidneys perfused for 2 h at 12 ml/min, with hematocrit of 0.09 ± 0.005 and PO 2 of 443 ± 67 mmHg, EPO mRNA levels were similar to the baseline levels measured in nonperfused contralateral kidneys from the same animals. When perfusions were performed under identical conditions but at a PO 2 of 32 ± 4 mmHg, EPO mRNA increased ~16-fold. In contrast, graded concentrations of cyanide (10, 100, and 300 μM and 1 mM), antimycin (0.01, 0.1, 0.5, and 1 μM), and oligomycin (0.01, 0.1, and 1 μM) did not alter EPO mRNA in well-oxygenated perfused kidneys. However, in kidneys perfused at low PO 2 with a high concentration of each inhibitor, EPO mRNA levels were increased, demonstrating that the ability to respond to hypoxia was retained. Thus inhibitors of oxidative phosphorylation did not mimic the effects of hypoxia, indicating that oxygen-dependent expression of the EPO gene in the kidney is not effected through hypoxic compromise of oxidative phosphorylation.

Type

Journal article

Journal

American Journal of Physiology - Renal Fluid and Electrolyte Physiology

Publication Date

01/12/1991

Volume

261